"Heterografts" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tissues, cells or organs transplanted between animals of different species.
| Descriptor ID |
D064593
|
| MeSH Number(s) |
A01.941.875
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Heterografts".
Below are MeSH descriptors whose meaning is more specific than "Heterografts".
This graph shows the total number of publications written about "Heterografts" by people in this website by year, and whether "Heterografts" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 8 | 8 |
| 2014 | 0 | 15 | 15 |
| 2015 | 0 | 14 | 14 |
| 2016 | 1 | 5 | 6 |
| 2017 | 0 | 16 | 16 |
| 2018 | 1 | 9 | 10 |
| 2019 | 1 | 5 | 6 |
| 2020 | 1 | 8 | 9 |
| 2021 | 2 | 9 | 11 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 5 | 5 |
| 2025 | 2 | 1 | 3 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heterografts" by people in Profiles.
-
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat Cancer. 2022 02; 3(2):232-250.
-
Surgical Procedure for Implantation of Human Tumor Tissue into the Epithelium-Free Mammary Fat Pad of Immunocompromised Mice to Generate Patient-Derived Xenografts (PDX). Methods Mol Biol. 2022; 2471:195-207.
-
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment. Nat Commun. 2021 08 24; 12(1):5086.
-
Long non-coding RNA AFAP1-AS1 accelerates lung cancer cells migration and invasion by interacting with SNIP1 to upregulate c-Myc. Signal Transduct Target Ther. 2021 06 25; 6(1):240.
-
CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer. Breast Cancer Res. 2019 12 04; 21(1):134.
-
H22954, a novel long non-coding RNA down-regulated in AML, inhibits cancer growth in a BCL-2-dependent mechanism. Cancer Lett. 2019 07 10; 454:26-36.
-
Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer. Breast Cancer Res Treat. 2019 Jun; 175(2):339-351.
-
CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation. Mol Cancer Res. 2019 02; 17(2):604-617.
-
TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis. J Clin Invest. 2018 07 02; 128(7):3129-3143.
-
REG? Controls Hippo Signaling and Reciprocal NF-?B-YAP Regulation to Promote Colon Cancer. Clin Cancer Res. 2018 04 15; 24(8):2015-2025.